Fig. 1From: Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cellsSurface expression of NKG2D ligands on TNBC cell lines. A panel of human TNBC cell lines were stained with recombinant NKG2D-Fc or specific antibodies that recognize MICA/B; ULBP-1, ULBP-2/5/6, ULBP-3, or ULBP-4 (solid line histogram); matched isotype or irrelevant recombinant protein-Fc controls (dashed line histogram) and analyzed by flow cytometry. A breast cancer cell line, MCF7, was used as a positive controlBack to article page